|
|
|
||
|
|
|
||
|
|
°¡Àå Àß ÆÈ¸®´Â ¾àǰ¿¡ ´ëÇÑ Á¤º¸¿Í °¡°Ý |
|
|
|
Tykerb(ŸÀÌÄ¿ºê): ¼ººÐ¸í Lapatinib, HER2¾ç¼ºÀÇ ÁøÇ༺ ¶Ç´Â ÀüÀ̼º À¯¹æ¾ÏÀÇ »õ·Î¿î Ä¡·á¾àÀÔ´Ï´Ù. Vectibix(º¤Æ¼ºò½º): ¼ººÐ¸í Panitumumab, Ç¥ÁØÈÇÐ ¿ä¹ý ÈÄÀÇ ÀüÀ̼º ´ëÀå, Á÷Àå¾Ï Ä¡·á¾àÀÔ´Ï´Ù. Sutent(¼öÅÙÆ®): ¼ººÐ¸í Sunitinib, ±Û¸®º¤(Glivec)¿¡ Ä¡·áÀúÇ×¼ºÀ» º¸ÀÎ À§Àå±âÁú¾Ï(GIST) ȯÀÚÀÇ Ä¡·á¾àÀÔ´Ï´Ù. Lucentis(·ç¼¾Æ¼½º): ¼ººÐ¸í Ranibizumab, Ȳ¹Ýº¯¼º(AMD) ȯÀÚÀÇ Ä¡·á¾àÀÔ´Ï´Ù. Nexavar(³Ø»ç¹Ù): ¼ººÐ¸í Sorafenib, ½Å¼¼Æ÷¾Ï Ä¡·á¸¦ À§ÇÑ ¾àÀÔ´Ï´Ù Tarceva(Ÿ¸£¼¼¹Ù): ¼ººÐ¸í Erlotinib, ºñ¼Ò¼¼Æ÷¼º Æó¾Ï(NSCLC) Ä¡·á¸¦ À§ÇÑ ¾àÀÔ´Ï´Ù Avastin(¾Æ¹Ù½ºÆ¾): ¼ººÐ¸í Bevacizumab, ÀüÀ̼º ´ëÀå¾ÏÀÇ Ä¡·á¾àÀÔ´Ï´Ù Erbitux(¾óºñÅö½º): ¼ººÐ¸í Cetuximab, ÁøÇ༺ ´ëÀå¾ÏÀÇ Ä¡·á¾àÀÔ´Ï´Ù. Tamiflu(Ÿ¹ÌÇ÷ç): ´º¶ó¹Ì´Ï´Ù¾ÆÁ¦¸¦ ¾ïÁ¦ÇÏ¿© Á¶·ùÀÎÇ®·ç¿£ÀÚ¸¦ Ä¡·á ÇÕ´Ï´Ù. Relenza(¸®·»ÀÚ): ´º¶ó¹Ì´Ï´Ù¾ÆÁ¦¸¦ ¾ïÁ¦ÇÏ¿© Á¶·ùÀÎÇ÷翣ÀÚ¸¦ Ä¡·á ÇÕ´Ï´Ù |
µµ¸Å¾÷ÀÚ Àü¿ë |
||
|
Ưº° ÆÇ¸Å! |
|
||
|
|
|
||
|
½ÅÁ¾ ÀÎÇ÷翣ÀÚ |
|
||
|
|
|
||
|
|
|
||
|
¹«·á Á¤º¸ ¹Þ¾Æº¸±â |
|
||
|
Ä£±¸¿¡°Ô Farmamondo¸¦ ¼Ò°³ÇÕ´Ï´Ù. |
|
||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
Farmamondo, Via Volta 2, Chiasso
(Switzerland) |
|
||
|
|
||||